Literature DB >> 8076517

Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor.

H S Coles1, J F Burne, M C Raff.   

Abstract

Although normal cell death is known to occur in many developing vertebrate organs, it has not been thought to play an important part in the development of the mammalian kidney. We show here that normal cell death is found in both the nephrogenic region and medullary papilla of the developing rat kidney and, in each of these areas, it follows a distinct developmental time course. As many as 3% of the cells in these areas have a typical apoptotic morphology and the dead cells seem to be cleared rapidly (within 1-2 hours) by phagocytosis by neighbouring parenchymal cells. These values are similar to those in vertebrate neural tissues where 50% or more of the cells die during normal development, suggesting that large-scale death is a normal feature of kidney development. We also show that in vivo treatment with epidermal growth factor inhibits cell death in the developing kidney, consistent with the possibility that the cells normally die because they lack sufficient survival factors. Our findings suggest that the extent of normal cell death in developing animals is still greatly underestimated and they raise the possibility that many of these cell deaths may reflect limiting amounts of survival factors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8076517     DOI: 10.1242/dev.118.3.777

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  70 in total

1.  Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall.

Authors:  E DiFederico; O Genbacev; S J Fisher
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 2.  Programmed cell death in the terminal endbud.

Authors:  R C Humphreys
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

3.  Nephric lineage specification by Pax2 and Pax8.

Authors:  Maxime Bouchard; Abdallah Souabni; Markus Mandler; Annette Neubüser; Meinrad Busslinger
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

4.  Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta.

Authors:  M Moser; A Pscherer; C Roth; J Becker; G Mücher; K Zerres; C Dixkens; J Weis; L Guay-Woodford; R Buettner; R Fässler
Journal:  Genes Dev       Date:  1997-08-01       Impact factor: 11.361

5.  Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros.

Authors:  J Barasch; J Yang; J Qiao; P Tempst; H Erdjument-Bromage; W Leung; J A Oliver
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

6.  Apoptosis in cancer: archaeology, functional relevance and exploitation in novel treatment strategies.

Authors:  E F Gaffney
Journal:  Ir J Med Sci       Date:  2004 Jan-Mar       Impact factor: 1.568

7.  Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression.

Authors:  L A Bruggeman; S Dikman; C Meng; S E Quaggin; T M Coffman; P E Klotman
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

8.  Prenatal corticosterone exposure results in altered AT1/AT2, nephron deficit and hypertension in the rat offspring.

Authors:  Reetu R Singh; Luise A Cullen-McEwen; Michelle M Kett; Wee-Ming Boon; John Dowling; John F Bertram; Karen M Moritz
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

9.  Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis.

Authors:  A J Baker; A Mooney; J Hughes; D Lombardi; R J Johnson; J Savill
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  Bcl-2 protein expression during murine development.

Authors:  D V Novack; S J Korsmeyer
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.